Cryptococcal Infection in Transplant Kidney Manifesting as Chronic Allograft Dysfunction
- PMID: 28904437
- PMCID: PMC5590418
- DOI: 10.4103/ijn.IJN_298_16
Cryptococcal Infection in Transplant Kidney Manifesting as Chronic Allograft Dysfunction
Abstract
Invasive fungal infections (IFIs) are a significant cause of morbidity in solid organ transplant (SOT) recipients. Common causes among them are Aspergillus, Candida, and Cryptococcus. Antifungal prophylaxis has led to decrease in overall incidence of IFI; however, there is very little decline in the incidence of Cryptococcal infections of SOT recipients because effective prophylaxis is not available against this infectious agent. Spectrum of manifestation of Cryptococcal infection varies in immunocompetent and immunocompromised host with subclinical and self-limiting with lungs being the primary site in immunocompetent and central nervous system as the most common site in an immunocompromised host. Other preferred sites are cutaneous, pulmonary, urinary tract (prostate) and the bone. Herein, we describe a young adult renal transplant recipient male diagnosed as a rare case of biopsy proven Cryptococcal infection in transplant kidney manifesting as chronic allograft dysfunction.
Keywords: Chronic allograft dysfunction; Cryptococcosis; invasive fungal infections.
Conflict of interest statement
There are no conflicts of interest.
Figures
References
-
- Singh N, Forrest G. AST Infectious Diseases Community of Practice. Cryptococcosis in solid organ transplant recipients. Am J Transplant. 2009;9(Suppl 4):S192–8. - PubMed
-
- Pappas PG, Alexander BD, Andes DR, Hadley S, Kauffman CA, Freifeld A, et al. Invasive fungal infections among organ transplant recipients: Results of the Transplant-Associated Infection Surveillance Network (TRANSNET) Clin Infect Dis. 2010;50:1101–11. - PubMed
-
- Fortún J, Martín-Davila P, Moreno S, Barcena R, de Vicente E, Honrubia A, et al. Prevention of invasive fungal infections in liver transplant recipients: The role of prophylaxis with lipid formulations of amphotericin B in high-risk patients. J Antimicrob Chemother. 2003;52:813–9. - PubMed
-
- Singh N, Paterson DL, Gayowski T, Wagener MM, Marino IR. Preemptive prophylaxis with a lipid preparation of amphotericin B for invasive fungal infections in liver transplant recipients requiring renal replacement therapy. Transplantation. 2001;71:910–3. - PubMed
Publication types
LinkOut - more resources
Full Text Sources
Other Literature Sources
